Search
B. David Zarley
B. David Zarley is a senior staff writer for Freethink, where he covers health and medicine, including infectious disease, psychedelic research, mental health, and the brain. A graduate of SUNY Fredonia, his work has also appeared in The Atlantic, The Verge, Jezebel, Frieze, Sports Illustrated, VICE, Paste Magazine, and numerous other publications. He lives in Chicago.
Read Less
Retatrutide, Eli Lilly's innovative "triple g" drug, is setting new standards in the fight against obesity.
End of life patients face mental health challenges uniquely existential and spiritual in nature — but psychedelics are emerging as a possible solution to relieve the suffering.
New research shows psychedelics activate receptors inside brain cells that other compounds, like serotonin, cannot.
Most patients with cancer die from metastasis. Stopping it would be a major advance in cancer therapy.
Fluphenazine, once used to treat schizophrenia, is capable of blocking a compound connected to chronic pain.
The synthetic cartilage was made from cellulose fibers — the stuff found in wood — mixed with a goo called polyvinyl alcohol.
Heart muscle is shaped like a spiral, a mystery that has eluded scientists since 1669. New research has recreated the structure.
The world is aging, and with age comes vision decline. New research may have found how to improve eyesight in an accessible way.